illumiSonics
Waterloo, CA · 2 known investors
Find your way into illumiSonics
Sign up to see every warm intro you have to illumiSonics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the illumiSonics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
illumiSonics develops MLI™, a proprietary molecular imaging platform that extracts diagnostic information from unstained tissue samples for use in pathology, surgical imaging, and ophthalmology. The technology enables virtual histology and AI-powered diagnostics without destructive sample consumption, targeting pharmaceutical companies, clinical labs, and surgical centers.
Founders & leadership
DJ
Dr. John MackeyChief Executive Officer
PH
Parsin Haji RezaNamed on SEC filing
JS
Jochen SchweizerNamed on SEC filing
BJ
Bruce JohnsonNamed on SEC filing
RG
Rocky GanskeNamed on SEC filing
JM
John MackeyNamed on SEC filing
Board
KF

Investors · 2
Reported raises · per SEC filings
Form D private placements$366.2K disclosed across 1 round · 2022
▶$366.2KraisedJul 2022 · 2 investors · Other Health CareRule 506(c)
▶$366.2KraisedJul 2022 · 2 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Parsin Haji RezaExecutive Officer, Director
- Jochen SchweizerExecutive Officer
- Kevin FaheyDirector
- Bruce JohnsonDirector
- Rocky GanskeExecutive Officer
- John MackeyExecutive Officer, Director
- Offering amount
- $366.2K
- Amount sold
- $366.2K
- First sale
- May 2022
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does illumiSonics do?
- illumiSonics develops MLI™, a proprietary molecular imaging platform that extracts diagnostic information from unstained tissue samples for use in pathology, surgical imaging, and ophthalmology. The technology enables virtual histology and AI-powered diagnostics without destructive sample consumption, targeting pharmaceutical companies, clinical labs, and surgical centers.
- Who are illumiSonics's investors?
- illumiSonics's investors include Waterloo Accelerator Centre, Council.
- How much funding has illumiSonics raised?
- illumiSonics has disclosed $366.2K raised across 1 round.
- Where is illumiSonics headquartered?
- illumiSonics is headquartered in Waterloo, CA.


